A 49-year-old woman with alcohol-related cirrhosis (Child-Pugh B8, MELD 11) and 11 months of abstinence presented with per ...
Alcohol-associated liver disease (ALD) is a major global health problem and a leading cause of liver-related morbidity and ...
Background Duodenal cancer is a leading cause of cancer-related mortality in familial adenomatous polyposis (FAP), yet the ...
BACKGROUND Thrombocytopenia in cirrhotic patients may be due to deficient production of thrombopoietin. AIMS To determine the relation between thrombopoietin and thrombocytopenia in cirrhotic patients ...
1 Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands 2 Department of Nuclear Medicine, Academic Medical Center, Amsterdam, The Netherlands 3 Department ...
Objective To compare efficacy of pharmacotherapies for chronic idiopathic constipation (CIC) based on comparisons to placebo using Bayesian network meta-analysis. Data sources We conducted searches ...
3 Department of Paediatrics, Meander Medisch Centrum, Amersfoort, the Netherlands 4 MediServ BV/Clinical Research facilities BV, Schaijk, the Netherlands Correspondence to: Dr W P Voskuijl Department ...
Background: Impaired gastric accommodation may lead to dyspeptic symptoms. A non-invasive method using single photon emission computed tomography (SPECT) has been developed to measure gastric volumes.
Background and aim: There are limited evidence based data concerning the use of azathioprine in ulcerative colitis. We aimed to compare the efficacy of azathioprine and oral 5-aminosalicylic acid in ...
Objective The aetiology of primary biliary cirrhosis (PBC) is largely unknown. Previous studies have indicated that both environmental and genetic risk factors may be important. Design We undertook a ...
Correspondence to Professor Jianguo Chen, Department of Etiology, Qidong Liver Cancer Institute, Qidong People’s Hospital, Qidong 226200, China; chenjg{at}ntu.edu.cn and Professor Hong Tu, State Key ...
The recent conditional US Food and Drug Administration (FDA) approval of two therapies, resmetirom (Rezdiffra) and semaglutide (Wegovy), marks the first time clinicians have pharmacological therapy ...